HitGen, Inc. Hits Day High with 7.64% Surge in Stock Price

HitGen, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance, gaining 7.64% on June 29, 2026. The stock reached an intraday high of CNY 33.45, reflecting strong market activity. Over the past week, HitGen has shown a remarkable 14.59% increase, significantly outperforming the China Shanghai Composite, which declined by 2.14% during the same period. In terms of annual performance, HitGen has surged by 102.16%, while the broader market index has only seen an 18.97% rise. Year-to-date, the company has achieved a 40.0% increase, further solidifying its position as a reliable performer in the market. Key financial metrics highlight HitGen's robust growth, including a net profit increase of 114.98% and a pre-tax profit of CNY 43.75 million, which has grown by 150.73%. The company also reported its highest operating cash flow at CNY 204.8 million and a return on capital employed (ROCE) of 8.01%. With a market capitalization of CNY 10,782 million, HitGen continues to demonstrate strong financial health and market resilience.